Please use this identifier to cite or link to this item:
https://repository.unej.ac.id/xmlui/handle/123456789/2700
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ifada | |
dc.date.accessioned | 2013-12-03T02:50:39Z | |
dc.date.available | 2013-12-03T02:50:39Z | |
dc.date.issued | 2013-12-03 | |
dc.identifier.nim | 082210101047 | |
dc.identifier.uri | http://repository.unej.ac.id/handle/123456789/2700 | |
dc.description.abstract | A new compound from 5-fluorouracil (5-FU) derivatives, 1-(4- methoxybenzoyloxymethyl)-5-fluorouracil has been synthesized in a two steps reaction, alkylation (5-FU and formaldehyde to form 1-hydroxymethyl-5- fluorouracil) and esterification (1-hydroxymethyl-5-fluorouracil and 4- methoxybenzoylchloride to form 1-(4-methoxybenzoyloxymethyl)-5-fluorouracil). Reaction product purified by chromatography column, the product has been characteryzed for physical apperance is a yellowish white, crystal and melting range 168-169OC. Based on the FTIR and 1H-NMR spectra, it showed that the purified product does not contain a single compound. This fact is supported by Thin Layer Chromatography (TLC) result showing two spots for the pressure of 1-(4- methoxybenzoyloxymethyl)-5-fluorouracil and 4-methoxybenzoate acid. | en_US |
dc.relation.ispartofseries | 082210101047; | |
dc.subject | 5-fluorouracil derivates, anticancer, 1-(4-methoxybenzoyloxymethyl)-5- fluorouracil, benzoylation | en_US |
dc.title | Sistensis 1-(4-Metoksibenzoiloksimetil)-5-Fluorourasil Sebagai Upaya Pengembagan Obat Antikanker | en_US |
dc.type | Other | en_US |
Appears in Collections: | UT-Faculty of Pharmacy |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Ifada - 082210101047_01.pdf | 671.24 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
Admin Tools